As drug prices in the US fluctuate, pharma companies may look to other regions for opportunity.Pharmaceutical Executive: How will pharma companies react to the administration’s efforts?Dr. William Soliman: We’ve seen Pfizer doing a deal with Trump, and I think other companies will follow. If they can come to a compromise for even just some branded […]
